Supplemental Material, 812778_supplemental_appendices - Potential Use of Artificial Intelligence for Regulatory Intelligence: Biopharmaceutical Industry’s Views

Supplemental Material, 812778_supplemental_appendices for Potential Use of Artificial Intelligence for Regulatory Intelligence: Biopharmaceutical Industry’s Views by Mark Mayer, Angelica Canedo, Tam Dinh, Madelyn Low, Ariel Ortiz, and Chloé Garay in Therapeutic Innovation & Regulatory Science